Synchronous Bilateral Ovarian Carcinomas With Right Mesonephric-like Adenocarcinoma and Left High-grade Serous Carcinoma: A Case Report and Review of the Literature

2024-9-10

Origin of Peritoneal Cancer With Features of High-grade Serous Carcinoma: A Detailed Molecular Analysis

2024-9-10

Serous Tubal Intraepithelial Carcinoma After Neoadjuvant Chemotherapy: A Report of 2 Cases

2024-8-22

High-grade Endometrial Carcinoma With Serous and Colorectal Carcinoma-like Components: Unique Morphology in Correlation With Immunohistochemical and Molecular Findings

2024-8-12

Acantholytic Dyskeratoses of the Vulva: Clinicopathologic Characterization of 16 Cases and Review of the Literature

2024-8-12

Nonsclerotic Lichen Sclerosus of Vulva: A Clinicopathologic Analysis

2024-8-12

β-catenin, PAX2, and PTEN Aberrancy Across the Spectrum of Endometrioid Ovarian Lesions

2024-7-30

HER2 Status in Low-grade Serous Ovarian Tumors

2024-7-30

Metastatic Leiomyoma With Malignant Transformation Harboring RAB2A-PLAG1 Fusion—A Case Report and Review With Molecular Analysis

2024-7-29

Prognostic Significance of “High” Tumor Budding and “High” Poorly Differentiated Clusters in Endometrial Carcinomas: Independent Predictors of Lymphovascular Space Invasion and Lymph Node Metastasis

2024-7-29

“Uterine-type” Extra-uterine High-grade Sarcoma of the Rectovaginal Septum: Case Report and Review of Literature

2024-7-29

Whole-exome Sequence Analysis of Gastric-type Adenocarcinoma of the Uterine Cervix and Adjacent Lobular Endocervical Glandular Hyperplasia in the Same Case

2024-7-29

Robert H. Young, MD, FRCPath. Reflections on His 50th Year in Medicine: An Interview With Dr. Philip B. Clement

2024-7-29

Association of Local and Distant Organ Metastases With MELF Pattern in Endometrial Cancer

2024-7-29

How Can “No Specific Molecular Profile” Heterogeneity be Reduced in Molecularly Classified Endometrial Cancer?: Prognostic Significance of L1 Cell Adhesion Molecule

2024-7-29

Confusing Histopathological Features and HPV Testing Results in Vulvar Squamous Cell Carcinoma Arising in a Young Woman: A Case Solved Using Next-Generation Sequencing

2024-7-24

Leiomyosarcomas of the Visceral Adnexal and Uterine Ligaments and Adnexal Connective Tissue: Immunohistochemical, Molecular Genetic, and MDM2 Fluorescence In Situ Hybridization Analysis

2024-7-23

A Population-based Study Investigating the Incidence of Human Papillomavirus–Associated and Human Papillomavirus–Independent Cervical Adenocarcinomas

2024-7-22

Superficial and Invasive Spread of High-grade Squamous Intraepithelial Lesion and Squamous Cell Carcinoma: A Case Report

2024-7-22

Morphomolecular Correlation and Clinicopathologic Analysis in Endometrial Carcinoma

2024-7-8

Human Papilloma Virus–Independent/p53abnormal Keratinizing Squamous Cell Carcinoma of the Uterine Cervix Associated With Uterine Prolapse

2024-7-1

Prevalence of Occult Ovarian Cancer and Metastatic Breast Cancer in Ovarian Ablation Specimens of Patients With Hormone Receptor-Positive Breast Cancer: Implications for Tissue Sampling Strategies, Early Ovarian Cancer Detection and Resource Utilization

2024-6-26

LINE-1 ORF1p is a Promising Biomarker in Cervical Intraepithelial Neoplasia Degree Assessment

2024-6-26

Mixed Gestational Trophoblastic Tumors—Challenging Clinicopathological Presentations

2024-6-26

The Prognostic Value of Tumor Cell Clusters in the Fallopian Tube Lumen in Stage I Endometrioid Carcinoma

2024-6-25

Comparison of PD-L1, VISTA, LAG-3, and GAL-3 Expressions and Their Relationships to Mismatch Repair Protein and p53 Expression in 529 Cases of Endometrial Carcinoma

2024-6-13

Folate Receptor Immunohistochemical Staining and Gynecologic Tumors: Initial Experience With 216 Cases

2024-6-12

Folate Receptor Alpha Expression and the Tumor Immune Microenvironment in Patients with Cervical Cancer

2024-6-12

Synchronous Endometrial and Ovarian Endometrioid Carcinoma With MUTYH Germline Mutation: A Case Report With Genetic Analysis

2024-6-11

Targetable ERBB2/HER2 Mutations in Gynecologic Malignancies: Clinicopathological, Immunohistochemical, and Molecular Correlations

2024-6-10

TRPS1 Is Consistently Expressed in Hidradenoma Papilliferum

2024-6-10

Molecular Surrogate Subtypes of Ovarian and Peritoneal Low-grade Serous Carcinoma

2024-6-10

Stathmin is an Independent Prognostic Marker of Poor Outcome in Uterine Leiomyosarcoma

2024-6-4

Novel Androgen Receptor Splice Variant 7 in Gynecologic Tumors

2024-5-29

Stromal p16 and SATB2 Expression Does Not Distinguish Atypical Polypoid Adenomyoma (APA) From its Benign Mimics

2024-5-29

POLE-mutated Endometrial “Carcinosarcoma”

2024-5-29

Improved Risk Prediction in Human Papillomavirus–Associated Endocervical Adenocarcinoma Through Assessment of Binary Silva Pattern-based Classification: An International Multicenter Retrospective Observational Study Led by the International Society of Gynecological Pathologists (ISGyP)

2024-5-20

Diagnosis and Management of an Enlarging Placental Immature Teratoma: A Case Report

2024-5-14

p53 Abnormal (Copy Number High) Endometrioid Endometrial Carcinoma Has a Prognosis Indistinguishable From Serous Carcinoma

2024-5-9

Napsin A Immunoreactivity in “Hobnail” Epithelium in Benign Endometrial and Endocervical Polyps

2024-5-6

High-grade Serous Carcinoma Occurring in a Serous Cystadenoma on the Background of a Serous Tubal Intraepithelial Carcinoma (STIC)-like Lesion: A Case Report With Literature Review

2024-4-18

Erythrasma of the Vulva: An Invisible Dermatosis

2024-4-9

Human Papillomavirus–Associated Multiphenotypic Carcinoma: First Description of a Vulval Case

2024-4-9

Clinicopathologic Characteristics of a Single-institution Cohort of Ovarian Adult Granulosa Cell Tumors, With Biomarker and Therapeutic Implications Utilizing the Detection of Androgen, Estrogen, and Progesterone Hormone Receptor Expression by Immunohistochemistry

2024-3-27

Endometrial Cancer in a Family With RAD51D Gene Mutation

2024-3-25

A Novel EPC1::KDM2B Fusion in High-grade Endometrial Stromal Sarcoma

2024-3-11

Premature Classification of Early-stage Endometrioid Ovarian Carcinoma With Mesonephric-like Differentiation as Mesonephric-like Adenocarcinoma

2024-3-4

HER2-low and Overexpression in Mucinous Ovarian Cancer: Analysis of ASCO/CAP and ToGA Immunohistochemical Scoring

2024-3-4

Characteristics and Significance of Tertiary Lymphoid Structures Based on Molecular Subtypes in Endometrial Cancer

2024-2-23

Tumor Budding, Poorly Differentiated Clusters, and Stroma Percentage in Uterine Endometrioid Carcinomas Are Morphologic Findings Associated With Adverse Clinical Outcomes

2024-2-22